PACIRA BIOSCIENCES, INC. financials

  1. Home
  2. Financials
  3. PCRX
PCRX CIK 0001396814

Source: EDGAR filings · Built 2026-06-02T03:47:43Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 136.66M 178.75M 139.49M 115.20M 79.85M 39.23M
EBITDA 110.21M 5.41M 163.25M 151.53M 118.47M 66.26M
Working Capital 427.38M 435.21M 412.61M 350.56M 344.93M 398.30M
Net Debt 259.66M 362.08M 432.75M 659.25M 183.77M 441.17M
Gross Margin 79.39% 75.69% 72.64% 70.11% 74.10% 72.69%
Operating Margin 2.64% -10.47% 12.99% 9.00% 16.61% 10.79%
Net Margin 0.97% -14.20% 6.22% 2.39% 7.75% 33.87%
Return on Equity (ROE) 1.01% -12.79% 4.82% 2.05% 5.75% 23.48%
Return on Assets (ROA) 0.56% -6.41% 2.66% 0.95% 2.02% 11.42%
Current Ratio 4.54× 2.40× 5.24× 3.37× 1.66× 2.57×
Debt-to-Equity 0.60× 0.82× 0.67× 0.98× 1.05× 0.87×
Effective Tax Rate 58.31% -57.77% 32.00% -19.60% 25.57% -624.39%
Cash Conversion Ratio 21.61× -1.90× 3.69× 9.13× 2.99× 0.53×
Accruals Ratio -0.11× -0.19× -0.07× -0.08× -0.04× 0.05×
SBC % of Revenue 7.92% 7.30% 7.10% 7.21% 7.80% 9.29%
CapEx Coverage 9.91× 17.81× 10.20× 4.83× 2.74× 2.04×
Free Cash Flow Per Share $3.03 $3.87 $2.68 $2.48 $1.75 $0.90

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 161.75× — 37.91× 113.56× 65.40× 17.97×
P/FCF 8.53× 4.87× 12.57× 15.60× 34.38× 66.63×
FCF Yield 11.72% 20.52% 7.95% 6.41% 2.91% 1.50%
EV / EBITDA 12.01× 227.79× 12.26× 16.05× 24.27× 46.07×
P/S 1.46× 1.24× 2.32× 2.66× 4.97× 6.08×
P/B 1.54× 1.12× 1.80× 2.29× 3.69× 4.21×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 726.41M 700.97M 674.98M 666.82M 541.53M 429.65M
Revenues — — — — 541.53M 429.65M
Cost of Revenue 149.75M 170.43M 184.67M 199.29M 140.25M 117.33M
Research and Development Expense 117.31M 81.58M 76.26M 84.80M 55.55M 59.42M
Selling, General and Administrative Expense 368.76M 294.10M 269.44M 254.52M 199.34M 193.52M
Operating Income (Loss) 19.19M -73.37M 87.67M 60.02M 89.92M 46.35M
Income Tax Expense (Benefit) 9.84M 36.45M 19.75M -2.61M 14.42M -125.43M
Net Income (Loss) Attributable to Parent 7.03M -99.56M 41.95M 15.91M 41.98M 145.52M
Earnings Per Share, Basic $0.16 $-2.15 $0.91 $0.35 $0.95 $3.41
Weighted Average Number of Shares Outstanding, Basic 44.57M 46.24M 46.22M 45.52M 44.26M 42.67M
Earnings Per Share, Diluted $0.16 $-2.15 $0.89 $0.34 $0.92 $3.33
Weighted Average Number of Shares Outstanding, Diluted 45.04M 46.24M 51.98M 46.54M 45.63M 43.68M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 158.54M 276.77M 153.30M 104.14M 585.58M 99.96M
Assets, Current 547.97M 745.13M 509.99M 498.33M 866.05M 651.62M
Assets 1.26B 1.55B 1.57B 1.68B 2.08B 1.27B
Long-term Debt 372.19M 585.32M 522.44M 689.47M — —
Liabilities, Current 120.59M 309.92M 97.38M 147.77M 521.12M 253.33M
Long-term Debt, Excluding Current Maturities 372.19M 383.55M — — — —
Liabilities 571.81M 775.17M 704.26M 906.19M 1.34B 654.83M
Stockholders' Equity Attributable to Parent 693.11M 778.35M 870.13M 775.01M 730.41M 619.69M
Common Stock, Shares, Outstanding 41.12M 46.24M 46.48M 45.93M 44.73M 43.64M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 151.99M 189.39M 154.65M 145.27M 125.72M 77.03M
Payments to Acquire Property, Plant, and Equipment 15.33M 10.64M 15.16M 30.08M 45.87M 37.80M
Net Cash Provided by (Used in) Investing Activities 99.48M -83.28M 77.54M -225.19M -20.79M -277.61M
Payments for Repurchase of Common Stock 148.33M 25.00M 0 0 — —
Net Cash Provided by (Used in) Financing Activities -369.63M 17.36M -183.03M -401.53M 380.69M 222.30M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (PCRX CIK 0001396814), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

WEYS

WEYCO GROUP, INC.

EGY

VAALCO ENERGY INC /DE/

NPWR

NET Power Inc.